Eurogentec enters in the Therapeutic Oligonucleotides Manufacturing Field

Combining over 30 years of expertise in oligonucleotide synthesis to 20 years of biopharmaceutical GMP manufacturing, we now offer GMP therapeutic oligonucleotides manufacturing for early clinical phases.

GMP certification by the Belgium Authorities for the manufacturing and quality control of therapeutic oligonucleotides according to ICH Q7 is planned for Q1 2019.

 

 

Attached Files

Related articles

Products & Services

More
img-en-annual-closing-news-event-01.jpg

Annual Closing

Eurogentec will be closed from Friday the 25th of December 2020 until Friday the 1st of January 2021.